| Literature DB >> 35625449 |
Vitalijs Radenkovs1,2, Karina Juhnevica-Radenkova1, Jorens Kviesis3, Anda Valdovska2,4.
Abstract
The main intention of the present work was to investigate the ability of cellulose-degrading enzymes (C-DE) to release fatty acids (FAs) from complex matrices of cereal by-products during enzymatic hydrolysis (EH). For this purpose, three types of cereal bran (CB), i.e., wheat, rye, and oat, were used as lignocellulose substrates for three commercially available hydrolytic enzymes, i.e., Viscozyme L, Viscoferm, and Celluclast 1.5 L. The yield and composition of FAs after EH were assessed and compared with those obtained after either conventional Soxhlet extraction or after alkaline-assisted hydrolysis (A-AH) with 10% KOH in 80% MeOH and subsequent liquid-liquid extraction. The experimental results demonstrated that up to 6.3% and 43.7% higher total FA yield can be achieved by EH of rye bran using Celluclast 1.5 L than by A-AH and Soxhlet extraction, respectively. However, the application of Viscoferm for EH of wheat bran ensured up to 7.7% and 13.4% higher total FA yield than A-AH and Soxhlet extraction, respectively. The concentration of essential linolenic acid (C18:3) in lipids extracted after EH of rye bran with Celluclast 1.5 L was up to 24.4% and 57.0% higher than in lipids recovered by A-AH and Soxhlet extraction, respectively. In turn, the highest content of linolenic acid in wheat bran lipids was observed after EH with Viscoferm and Viscozyme L, ensuring 17.0% and 13.6% higher yield than after A-AH, respectively. SEM analysis confirmed substantial degradation of the CB matrix promoted by the ability of C-DE to act specifically on glycosidic bonds in cellulose and on xylosidic bonds in arabinoxylans, arabinans, and other arabinose-containing hemicelluloses. Structural alterations in cell integrity greatly contributed to the release of bound FAs and their better transfer into the extraction solvent. It has been shown that the proposed process of EH can be used for the efficient release of FAs from the CB matrix more sustainably and with a safer profile, thereby conveying greener production of FAs for certain purposes.Entities:
Keywords: biorefining; by-products; enzymatic hydrolysis; essential fatty acids; green-extraction; lipids; sustainability
Year: 2022 PMID: 35625449 PMCID: PMC9138263 DOI: 10.3390/biology11050721
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Nutritional compositions of cereal bran by-products derived from rye, wheat, and oat grains, g 100 g−1 DW.
| Major Nutrient Profiles, g 100 g−1 DW | ||||||
|---|---|---|---|---|---|---|
| Type of Bran | Moisture, % | Crude | Starch | Crude | Crude | Dietary |
| Wheat | 11.9 ± 0.2 a | 20.3 ± 0.4 c | 8.7 ± 0.0 c | 4.5 ± 0.1 b | 16.2 ± 0.4 a | 46.5 ± 2.1 a |
| Rye | 11.7 ± 0.2 a | 30.9 ± 0.5 b | 18.6 ± 0.0 b | 3.8 ± 0.1 c | 16.9 ± 0.5 a | 36.0 ± 1.9 b |
| Oat | 12.4 ± 0.3 a | 50.0 ± 0.9 a | 47.6 ± 0.9 a | 6.7 ± 0.5 a | 14.0 ± 0.7 b | 14.0 ± 1.7 c |
Note: Values are means ± SD values of triplicates (n = 3). Means within the same column with different superscript letters (a, b, and c) are significantly different at p ≤ 0.05; DW—dry weight; SD—standard deviation.
List of commercial cellulose-degrading enzymes applied in this study.
| Commercial | Declared | Enzyme | Source | EC |
|---|---|---|---|---|
| Viscozyme® L | 100 FBG g−1 |
| 3.2.1.6 | |
| Viscoferm® | 222 FBG g−1 | 3.2.1.6 | ||
| Celluclast® 1.5 L | 700 EGU g−1 |
|
| 3.2.1.4 |
Note: The main activities of enzymes used in this study are highlighted in bold. EC—enzyme commission; EGU—endoglucanase units; FBG—fungal β-glucanase units.
Figure 1Representative chromatographic separation of C4–C24 fatty acid methyl ester standards (black line) and FAMEs of lipids extracted after enzyme-assisted hydrolysis of rye bran using a Celluclast 1.5 L cellulose-degrading enzyme for 48 h (red line). Samples injection volume 1.0 uL (0.5 ug mL−1).
Figure 2Representative SEM micrographs of untreated wheat (A,B) and rye (C,D) and enzymatically hydrolyzed wheat (E,F) and rye (G,H) cereal bran samples accomplished by cellulose-degrading commercial multi-enzyme complex Viscozyme L for 48 h. Note: EPl—epidermal layer; Tc—tube cells; Cc—cross cells; STe—starchy endosperm; ALl—aleurone layer; Cm—cellulose microfibers; EPc—epidermal layer cracking; Vs—void spaces in testa and nucellar tissues.
The release of mono- and disaccharides after 48 h enzymatic hydrolysis of cereal bran samples using three enzyme complexes, i.e., Viscozyme L, Viscoferm, and Celluclast 1.5 L (g 1000 mL−1 of bran hydrolysate).
| Wheat Bran | Rye Bran | Oat Bran | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carbohydrate | Control | Vzym | Vferm | Cell | Control | Vzym | Vferm | Cell | Control | Vzym | Vferm | Cell |
| Xyl | 0.4 ± 0.0 d | 4.6 ± 0.0 c | 6.1 ± 0.2 b | 8.7 ± 0.1 a | 0.2 ± 0.0 d | 5.9 ± 0.2 c | 7.8 ± 0.3 b | 8.4 ± 0.1 a | n.d. | 0.8 ± 0.0 b | 1.2 ± 0.0 b | 2.1 ± 0.0 a |
| Ara | 0.5 ± 0.0 b | 2.7 ± 0.0 a | 3.2 ± 0.0 a | 2.8 ± 0.0 a | 0.6 ± 0.0 d | 6.2 ± 0.2 a | 4.9 ± 0.1 b | 1.5 ± 0.0 c | n.d. | 0.8 ± 0.0 a | 0.9 ± 0.0 a | n.d. |
| Fru | n.d. | 2.1 ± 0.0 a | 0.7 ± 0.0 b | 0.4 ± 0.0 b | 0.2 ± 0.0 c | 1.7 ± 0.0 a | 0.8 ± 0.0 b | 0.5 ± 0.0 b | n.d. | 1.6 ± 0.1 a | 0.3 ± 0.0 b | n.d. |
| Glu | n.d. | 17.9 ± 0.2 a | 7.9 ± 0.1 c | 11.3 ± 0.3 b | n.d. | 32.4 ± 0.4 a | 12.3 ± 0.2 c | 15.9 ± 0.3 b | n.d. | 47.6 ± 1.3 a | 16.1 ± 0.4 c | 18.4 ± 0.5 b |
| Suc | 1.9 ± 0.1 | n.d. | n.d. | n.d. | 2.9 ± 0.1 | n.d. | n.d. | n.d. | 0.9 ± 0.1 | n.d. | n.d. | n.d. |
| Mal | 0.3 ± 0.0 c | 0.9 ± 0.0 b | 0.9 ± 0.0 b | 3.1 ± 0.0 a | 0.2 ± 0.0 c | 1.9 ± 0.0 b | 0.7 ± 0.0 c | 2.6 ± 0.0 a | n.d. | 1.9 ± 0.0 a | 1.1 ± 0.0 b | 1.8 ± 0.0 ab |
| Tot | 3.1 ± 0.1 c | 28.2 ± 0.2 a | 18.8 ± 0.3 b | 28.6 ± 0.4 a | 4.1 ± 0.1 d | 48.6 ± 0.6 a | 26.5 ± 0.6 c | 28.9 ± 0.4 b | 0.9 ± 0.1 c | 52.9 ± 1.4 a | 19.7 ± 0.4 c | 22.9 ± 0.5 b |
Note: Values are means ± SD of triplicates (n = 3). Xyl—xylose; Ara—arabinose; Fru—fructose; Glu—glucose; Suc—sucrose; Mal—maltose; Tot—total sugar content; Vzym—commercial multi-enzyme preparation Viscozyme L; Vferm—commercial multi-enzyme preparation Viscoferm; Cell—commercial enzyme preparation Celluclast 1.5 L; n.d.—not detected; SD—standard deviation. The concentration of sugars in control CB samples is expressed as g 100 g−1 on a dry weight basis. Means within the same carbohydrate and bran type with different superscript letters (a,b,c,d) are significantly different at p ≤ 0.05.
Figure 3The content of lipids (% w/w) recovered from wheat, rye, and oat bran samples. Note: Values are means ± SD of triplicates (n = 3). SD—standard deviation.
Fatty acid composition of wheat bran lipids according to the pre-treatment method, mg g−1 lipid.
| Wheat | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fatty Acid | Soxhlet | 10% KOH | Vzym | Vferm | Cell | |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Myristate C14:0 | 1.0 | 0.0 | 0.8 | 0.1 | 1.5 | 0.0 | 1.8 | 0.2 | 0.9 | 0.0 |
| Pentadecanoate C15:0 | 0.8 | 0.0 | 1.0 | 0.1 | 0.8 | 0.0 | 0.8 | 0.0 | 0.7 | 0.0 |
| Palmitate C16:0 | 127.0 | 1.9 | 132.3 | 3.1 | 143.9 | 1.2 | 142.9 | 1.9 | 126.4 | 2.0 |
| Heptadecanoate C17:0 | 1.1 | 0.2 | 1.4 | 0.1 | 1.4 | 0.0 | 1.4 | 0.0 | 1.1 | 0.0 |
| Stearate C18:0 | 8.5 | 0.3 | 8.6 | 0.3 | 9.6 | 0.1 | 9.7 | 0.0 | 8.5 | 0.0 |
| Oleate C18:1 (c9) | 104.5 | 1.1 | 106.2 | 2.5 | 121.3 | 2.3 | 117.2 | 0.9 | 104.8 | 1.9 |
| Vaccenate C18:1 (t11) | 2.6 | 0.4 | 2.3 | 0.0 | 2.8 | 0.2 | 3.0 | 0.0 | 2.0 | 0.1 |
| Linoleate C18:2 (c9,c12) | 365.8 | 0.0 | 379.9 | 7.3 | 408.6 | 6.1 | 417.9 | 4.2 | 377.6 | 10.8 |
| Linolenate C18:3 (c9,c12,c15) | 22.0 | 0.9 | 21.9 | 0.4 | 24.9 | 0.6 | 25.7 | 0.5 | 23.6 | 0.8 |
| Arachidate C20:0 | 2.1 | 0.0 | 1.6 | 0.1 | 1.2 | 0.2 | 1.1 | 0.2 | 0.9 | 0.0 |
| CLA linoleate C18:2 (c9,t11) | 0.4 | 0.0 | 2.7 | 0.1 | 0.8 | 0.1 | 1.1 | 0.0 | 0.6 | 0.0 |
| CLA linoleate C18:2 (t10,c12) | 0.4 | 0.1 | 1.9 | 0.0 | 0.5 | 0.0 | 0.8 | 0.0 | 0.4 | 0.0 |
| 11-eicosenoate C20:1 (c11) | 3.3 | 0.3 | 3.1 | 0.1 | 3.7 | 0.0 | 3.7 | 0.1 | 3.3 | 0.1 |
| Eicosadienoate C20:2 (c11,c14) | BLQ | − | 0.5 | 0.1 | 0.5 | 0.1 | 0.6 | 0.1 | 0.5 | 0.0 |
| Behenate C22:0 | 3.1 | 0.7 | 3.3 | 0.2 | 2.2 | 0.2 | 2.0 | 0.1 | 1.7 | 0.1 |
| Erucate C22:1 (c9,c11) | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 |
| Tricosanoate C23:0 | 1.2 | 0.2 | 10.1 | 1.2 | 1.0 | 0.2 | 0.5 | 0.0 | 0.3 | 0.1 |
| Tetracosanoate C24:0 | 0.8 | 0.2 | 1.1 | 0.1 | 0.8 | 0.1 | 0.6 | 0.0 | 1.3 | 0.1 |
|
| 145.6 | 3.6 | 160.3 | 5.2 | 162.5 | 2.1 | 160.8 | 2.5 | 141.7 | 2.4 |
|
| 110.6 | 1.8 | 111.7 | 2.6 | 127.9 | 2.5 | 124.0 | 1.0 | 110.3 | 2.1 |
|
| 388.6 | 1.0 | 406.9 | 7.9 | 435.4 | 6.9 | 446.1 | 4.9 | 402.7 | 11.7 |
|
| 499.2 | 2.9 | 518.6 | 10.5 | 563.3 | 9.4 | 570.1 | 5.9 | 513.0 | 13.7 |
|
| 644.8 | 6.5 | 678.9 | 15.7 | 725.8 | 11.5 | 730.9 | 8.4 | 654.7 | 16.1 |
|
| 0.8 | 0.1 | 4.6 | 0.1 | 1.4 | 0.1 | 1.9 | 0.0 | 1.0 | 0.0 |
Note: Values are means ± SD of triplicates (n = 3). SFA—saturated fatty acids; MUFA—monounsaturated fatty acids; PUFA—polyunsaturated fatty acids; CLA—conjugated linoleic acid; Vzym—commercial multi-enzyme preparation Viscozyme L; Vferm—commercial multi-enzyme preparation Viscoferm; Cell—commercial enzyme preparation Celluclast 1.5 L; BLQ—below limit of quantification; SD—standard deviation.
Fatty acid composition of rye bran lipids according to the pre-treatment method, mg g−1 lipid.
| Rye | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fatty Acid | Soxhlet | 10% KOH | Vzym | Vferm | Cell | |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Myristate C14:0 | 1.3 | 0.0 | 0.9 | 0.0 | 1.4 | 0.1 | 0.9 | 0.0 | 1.0 | 0.1 |
| Pentadecanoate C15:0 | 0.8 | 0.0 | 1.2 | 0.0 | 0.8 | 0.1 | 0.9 | 0.1 | 0.8 | 0.1 |
| Palmitate C16:0 | 90.2 | 1.5 | 125.5 | 1.3 | 117.1 | 0.6 | 114.0 | 2.0 | 121.5 | 3.3 |
| Heptadecanoate C17:0 | 1.2 | 0.1 | 1.5 | 0.1 | 1.3 | 0.0 | 1.4 | 0.0 | 1.1 | 0.0 |
| Stearate C18:0 | 6.9 | 0.2 | 7.2 | 0.2 | 6.8 | 0.3 | 6.6 | 0.0 | 7.5 | 0.4 |
| Oleate C18:1 (c9) | 64.2 | 1.4 | 76.5 | 1.1 | 71.2 | 0.1 | 72.8 | 0.5 | 87.2 | 3.3 |
| Vaccenate C18:1 (t11) | 1.7 | 0.0 | 2.3 | 0.1 | 2.0 | 0.2 | 2.0 | 0.3 | 2.3 | 0.2 |
| Linoleate C18:2 (c9,c12) | 282.7 | 6.4 | 380.6 | 9.1 | 341.4 | 4.6 | 357.1 | 5.5 | 421.4 | 8.8 |
| Linolenate C18:3 (c9,c12,c15) | 21.6 | 0.5 | 27.2 | 0.7 | 25.0 | 0.2 | 26.5 | 0.6 | 33.9 | 0.9 |
| Arachidate C20:0 | 1.4 | 0.1 | 1.7 | 0.1 | 0.7 | 0.0 | 0.8 | 0.1 | 0.8 | 0.1 |
| CLA linoleate C18:2 (c9,t11) | 0.1 | 0.0 | 2.1 | 0.1 | 0.6 | 0.0 | 1.7 | 0.1 | 0.9 | 0.1 |
| CLA linoleate C18:2 (t10,c12) | 0.2 | 0.0 | 1.6 | 0.0 | 0.5 | 0.0 | 1.1 | 0.0 | 0.5 | 0.0 |
| 11-eicosenoate C20:1 (c11) | 3.9 | 0.3 | 4.3 | 0.1 | 4.0 | 0.1 | 4.1 | 0.2 | 5.2 | 0.1 |
| Eicosadienoate C20:2 (c11,c14) | BLQ | − | 0.8 | 0.1 | 0.5 | 0.1 | 0.8 | 0.0 | 0.8 | 0.0 |
| Behenate C22:0 | 2.7 | 0.1 | 2.9 | 0.1 | 2.0 | 0.1 | 1.8 | 0.0 | 1.6 | 0.1 |
| Erucate C22:1 (c9,c11) | 0.4 | 0.0 | 0.4 | 0.0 | 0.3 | 0.0 | 0.4 | 0.0 | 0.5 | 0.0 |
| Tricosanoate C23:0 | 0.9 | 0.1 | 12.9 | 1.1 | 0.7 | 0.0 | 0.4 | 0.0 | 0.3 | 0.0 |
| Tetracosanoate C24:0 | 1.1 | 0.1 | 1.1 | 0.1 | 0.7 | 0.1 | 0.6 | 0.1 | 4.6 | 0.0 |
|
| 106.4 | 2.2 | 154.9 | 3.1 | 131.6 | 1.2 | 127.2 | 2.3 | 139.2 | 4.1 |
|
| 70.3 | 1.8 | 83.5 | 1.4 | 77.6 | 0.4 | 79.3 | 1.0 | 95.2 | 3.6 |
|
| 304.6 | 6.9 | 412.3 | 9.9 | 368.1 | 4.9 | 387.2 | 6.2 | 457.3 | 9.9 |
|
| 374.9 | 8.6 | 495.8 | 0.0 | 445.7 | 5.4 | 466.5 | 7.2 | 552.5 | 13.5 |
|
| 481.3 | 10.9 | 650.7 | 14.3 | 577.3 | 6.5 | 593.7 | 9.5 | 691.7 | 17.6 |
|
| 0.3 | 0.0 | 3.7 | 0.1 | 1.2 | 0.0 | 2.9 | 0.1 | 1.3 | 0.1 |
Note: Values are means ± SD of triplicates (n = 3). SFA—saturated fatty acids; MUFA—monounsaturated fatty acids; PUFA—polyunsaturated fatty acids; CLA—conjugated linoleic acid; Vzym—commercial multi-enzyme preparation Viscozyme L; Vferm—commercial multi-enzyme preparation Viscoferm; Cell—commercial enzyme preparation Celluclast 1.5 L; BLQ—below limit of quantification; SD—standard deviation.
Fatty acid composition of oat bran lipids according to the pre-treatment method, mg g−1 lipid.
| Oat | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fatty Acid | Soxhlet | 10% KOH | Vzym | Vferm | Cell | |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Myristate C14:0 | 2.6 | 0.0 | 1.8 | 0.0 | 2.3 | 0.1 | 2.1 | 0.1 | 1.4 | 0.1 |
| Pentadecanoate C15:0 | BLQ | − | 0.2 | 0.0 | BLQ | − | BLQ | − | BLQ | − |
| Palmitate C16:0 | 150.5 | 0.1 | 149.0 | 0.7 | 144.4 | 0.4 | 137.0 | 2.4 | 143.1 | 0.5 |
| Heptadecanoate C17:0 | 1.0 | 0.0 | 1.0 | 0.0 | 0.7 | 0.0 | 1.0 | 0.1 | 1.0 | 0.0 |
| Stearate C18:0 | 16.6 | 0.2 | 14.4 | 0.2 | 14.0 | 0.2 | 12.4 | 0.2 | 15.8 | 0.1 |
| Oleate C18:1 (c9) | 343.9 | 4.8 | 300.0 | 1.0 | 270.6 | 1.8 | 266.6 | 1.3 | 332.6 | 0.8 |
| Vaccenate C18:1 (t11) | 4.2 | 0.1 | 4.7 | 0.1 | 3.7 | 0.0 | 2.4 | 0.3 | 3.2 | 0.4 |
| Linoleate C18:2 (c9,c12) | 323.7 | 4.5 | 321.4 | 2.9 | 272.9 | 1.0 | 272.0 | 1.3 | 314.1 | 3.0 |
| Linolenate C18:3 (c9,c12,c15) | 7.7 | 0.2 | 7.4 | 0.2 | 6.1 | 0.0 | 6.2 | 0.2 | 7.3 | 0.0 |
| Arachidate C20:0 | 0.9 | 0.8 | 0.7 | 0.1 | 0.5 | 0.0 | 0.7 | 0.1 | 0.7 | 0.1 |
| CLA linoleate C18:2 (c9,t11) | 0.4 | 0.0 | 1.7 | 0.1 | 0.3 | 0.0 | 0.9 | 0.0 | 0.3 | 0.0 |
| CLA linoleate C18:2 (t10,c12) | 0.1 | 0.0 | 1.1 | 0.1 | 0.3 | 0.0 | 0.5 | 0.0 | 0.2 | 0.0 |
| 11-eicosenoate C20:1 (c11) | 5.7 | 0.1 | 4.7 | 0.0 | 3.9 | 0.0 | 4.4 | 0.1 | 5.7 | 0.0 |
| Eicosadienoate C20:2 (c11,c14) | BLQ | − | BLQ | − | BLQ | − | 0.1 | 0.0 | 0.1 | 0.0 |
| Behenate C22:0 | 1.7 | 0.2 | 1.3 | 1.7 | 1.6 | 0.1 | 1.3 | 0.1 | 1.3 | 0.0 |
| Erucate C22:1 (c9,c11) | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 |
| Tricosanoate C23:0 | 1.0 | 0.1 | 1.6 | 0.7 | 0.7 | 0.2 | 0.7 | 0.0 | 0.6 | 0.0 |
| Tetracosanoate C24:0 | 0.5 | 0.0 | 0.4 | 0.0 | 0.4 | 0.0 | 0.3 | 0.0 | 0.4 | 0.0 |
|
| 174.8 | 1.4 | 170.5 | 3.7 | 164.6 | 1.0 | 155.5 | 2.9 | 164.3 | 0.9 |
|
| 353.9 | 5.1 | 309.4 | 1.1 | 278.4 | 1.9 | 273.5 | 1.7 | 341.7 | 1.2 |
|
| 331.8 | 4.7 | 331.7 | 3.3 | 279.6 | 1.1 | 279.7 | 1.6 | 322.0 | 3.1 |
|
| 685.7 | 9.8 | 641.1 | 4.4 | 558.0 | 3.0 | 553.2 | 3.3 | 663.6 | 4.3 |
|
| 860.6 | 11.2 | 811.6 | 8.1 | 722.6 | 4.0 | 708.7 | 6.2 | 828.0 | 5.2 |
|
| 0.4 | 0.0 | 2.8 | 0.2 | 0.6 | 0.0 | 1.3 | 0.1 | 0.4 | 0.0 |
Note: Values are means ± SD of triplicates (n = 3). SFA—saturated fatty acids; MUFA—monounsaturated fatty acids; PUFA—polyunsaturated fatty acids; CLA—conjugated linoleic acid; Vzym—commercial multi-enzyme preparation Viscozyme L; Vferm—commercial multi-enzyme preparation Viscoferm; Cell—commercial enzyme preparation Celluclast 1.5 L; BLQ—below limit of quantification; SD—standard deviation.